D. Killander
Karolinska University Hospital
10 Papers
291 Citations
D. Killander is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Prednisolone & Antigen. The author has an hindex of 9, co-authored 10 publications.
Chat about Author
Papers
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia
D. Killander,A. Dohlwitz,L. Engstedt,S. Franzén,Gösta Gahrton,B. Gullbring,Göran Holm,Arne Holmgren,S. Höglund,A. Killander,D. Lockner,Håkan Mellstedt,P. J. Moe,Jan Palmblad,Reizenstein P,K.O. Skårberg,B. Swedberg,A. M. Udén,B. Wadman,Leif Wide,L. Åhström +20 more
TL;DR: This time sequence, and in vitro experiments, suggest the formation of antigen‐antibody complexes which might be responsible for inactivation of Asnase and for the development of hypersensitive reactions.
148
Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
Göran Holm,Håkan Mellstedt,Magnus Björkholm,B. Johansson,D. Killander,R. Sundblad,G. Söderberg +6 more
TL;DR: Although the defects were usually more pronounced in patients with advanced disease, the impairment of T lymphocytes and their functions is present in all stages of Hodgkin's disease.
124
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
K. Ideström,Eva Kimby,Magnus Björkholm,Håkan Mellstedt,L. Engstedt,Gösta Gahrton,B. Johansson,D. Killander,K.-H. Robérts,A.-M. Stalfelt,A.-M. Udén,B. Wadman,S. Wählby +12 more
TL;DR: The therapeutic effect of prednimustine was equal to that of its constituents administrated separately, and treatment schedule C showed a slight advantage with regard to frequency of side effects.
58
Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Magnus Björkholm,Göran Holm,Håkan Mellstedt,B. Johansson,D. Killander,Sunblad R,G. Söderberg +6 more
TL;DR: The ability of certain lymphocyte functions to predict prognosis was equal or better than that of age and better than clinical staging, histopathology and symptoms.
44
Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
Gösta Gahrton,L. Engstedt,S. Franzén,B. Gullbring,Holm G,S. Höglund,Killander A,D. Killander,Lockner D,Håkan Mellstedt,Jan Palmblad,Reizenstein P,K.O. Skårberg,B. Swedberg,A. M. Udén +14 more
TL;DR: The addition of L‐asparaginase did not improve the response significantly in adults with acute leukemia and the over‐all complete remission rate was significantly higher in females than in males, and the rate below 50 years of age tended to be higher than above this age.
23